Cargando…

Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy

Serum fibroblast growth factor 23 (FGF23) levels and the renin-angiotensin-aldosterone system (RAAS) are elevated in chronic kidney disease (CKD) patients, and their association with left ventricular hypertrophy (LVH) has been reported. However, whether the FGF23 elevation is the cause or result of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okamoto, Kohei, Fujii, Hideki, Watanabe, Kentaro, Goto, Shunsuke, Kono, Keiji, Nishi, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758403/ https://www.ncbi.nlm.nih.gov/pubmed/35047715 http://dx.doi.org/10.1210/jendso/bvab187

Ejemplares similares

Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome–induced hypophosphatemia
por: Goto, Shunsuke, et al.
Publicado: (2016)

Renin-Angiotensin System Inhibitors Reduce Serum Asymmetric Dimethylarginine Levels and Oxidative Stress in Normotensive Patients with Chronic Kidney Disease
por: Fujii, Hideki, et al.
Publicado: (2014)

Erratum to: Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy
Publicado: (2022)

Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus
por: Watanabe, Shuhei, et al.
Publicado: (2020)

The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
por: Dörr, Katharina, et al.
Publicado: (2022)

Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis
por: Watanabe, Kentaro, et al.
Publicado: (2020)

Renal protective effects of astragalus root in rat models of chronic kidney disease
por: Goto, Shunsuke, et al.
Publicado: (2023)

Statin Use Influence on the Occurrence of Acute Kidney Injury in Patients with Peripheral Arterial Disease
por: Kanai, Daisuke, et al.
Publicado: (2022)

Newly Developed Rat Model of Chronic Kidney Disease–Mineral Bone Disorder
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Two Cases of Hypophosphatemia with Increased Renal Phosphate Excretion in Legionella Pneumonia
por: Watanabe, Shuhei, et al.
Publicado: (2016)

Clinical Implication of Consistently Strict Phosphate Control for Coronary and Valvular Calcification in Incident Patients Undergoing Hemodialysis
por: Shimizu, Mao, et al.
Publicado: (2023)

Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease
por: Fujii, Hideki, et al.
Publicado: (2012)

Clinical value of serum cholinesterase levels in Nephrotic syndrome: an observational study
por: Goto, Kimihiko, et al.
Publicado: (2022)

A Case of Fibrillary Glomerulonephritis with Fibril Deposition in the Arteriolar Wall and a Family History of Renal Disease
por: Watanabe, Kentaro, et al.
Publicado: (2017)

Comparison of two protocols for steroid pulse therapy in patients with IgA nephropathy: a retrospective observational study
por: Yamatani, Satoshi, et al.
Publicado: (2022)

Pregnant Patient on Hemodialysis Who Showed Remarkable Improvement of Severe Hyperparathyroidism by Strict Serum Phosphorus Control
por: Ito, Jun, et al.
Publicado: (2019)

Characteristics of coronary artery disease in chronic kidney disease
por: Fujii, Hideki, et al.
Publicado: (2019)

Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib
por: Saito, Kei, et al.
Publicado: (2020)

Inhibition of the renin-angiotensin system causes concentric hypertrophy of renal arterioles in mice and humans
por: Watanabe, Hirofumi, et al.
Publicado: (2021)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System
por: Latic, Nejla, et al.
Publicado: (2022)

Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
por: Campos, Luciana Aparecida, et al.
Publicado: (2012)

Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats
por: Piratello, Aline Cristina, et al.
Publicado: (2010)

Regulation of Male Fertility by the Renin-Angiotensin System
por: Gianzo, Marta, et al.
Publicado: (2020)

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
por: Grabner, Alexander, et al.
Publicado: (2017)

Cardiac FGF23 expression correlates with left ventricular hypertrophy in patients with chronic kidney disease
por: Leifheit-Nestler, Maren, et al.
Publicado: (2014)

The renin–angiotensin system in acute respiratory distress syndrome
por: Imai, Yumiko, et al.
Publicado: (2006)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16
por: Matsumoto, Emi, et al.
Publicado: (2013)

FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
por: Böckmann, Ineke, et al.
Publicado: (2019)

The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage
por: Goto, Kimihiko, et al.
Publicado: (2017)

An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro Studies
por: Ceravolo, Graziela S., et al.
Publicado: (2014)

Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway
por: Kishimoto, Hiroshi, et al.
Publicado: (2023)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway
por: Cotrin, Juliana Cordovil, et al.
Publicado: (2022)

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?
por: Miyazaki, Hiroki, et al.
Publicado: (2015)

Alisol B 23-acetate attenuates CKD progression by regulating the renin–angiotensin system and gut–kidney axis
por: Chen, Hua, et al.
Publicado: (2020)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ukv2f850k6su291h1oboq34jl9